New Case Report Published on Cosyntropin Use in Adrenal Insufficiency Study

A new case report was published on September 16, 2026, in JCEM Case Reports involving cosyntropin. The publication is titled "Glucocorticoid-induced adrenal insufficiency from a supplement containing undisclosed dexamethasone." This is a new addition to the medical literature as of the listed date. The report appears in JCEM Case Reports, a peer reviewed journal. No findings, outcomes, or conclusions from the report are detailed here beyond its title and publication venue. Cosyntropin is an approved compound, and its regulatory status remains unchanged by this publication. Readers interested in the topic can consult the original source for the full case details, methodology, and any reported outcomes. This brief only confirms that the publication exists and identifies its title, journal, and date. No dosing information, safety conclusions, or causation claims are made in this brief. For general background on cosyntropin, readers can refer to the compound overview.